TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $44.35M2009: $15.88M2010: -$11.32M2011: -$26.08M2012: -$3.36M2013: -$26.95M2014: -$55.60M2015: $10.87M2016: -$9.96M2017: -$29.46M2018: -$52.88M2019: -$70.32M2020: -$27.04M2021: -$6.04M2022: -$10.64M2023: $33.57M2024: $43.21M2025: $48.23M$48.23M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$48.23M+11.6%
2024$43.21M+28.7%
2023$33.57M+415.5%
2022-$10.64M-76.3%
2021-$6.04M+77.7%
2020-$27.04M+61.6%
2019-$70.32M-33.0%
2018-$52.88M-79.5%
2017-$29.46M-195.8%
2016-$9.96M-191.6%
2015$10.87M+119.6%
2014-$55.60M-106.3%
2013-$26.95M-702.7%
2012-$3.36M+87.1%
2011-$26.08M-130.3%
2010-$11.32M-171.3%
2009$15.88M-64.2%
2008$44.35M—